Pharmalot.. Pharmalittle.. As the weekend nears.. Catching up on Merck, Roche and..
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. Our agenda is extremely modest this time around. We expect to remove leaves from the Pharmalot campus, promenade with our official mascots and catch up on some work. And what about you? The great outdoors continue to beckon. There is still time to plan a holiday get-away. Or you could debate Starbucks coffee cups. Whatever you do, have a grand time. But be safe. See you soon…
The Trans-Pacific Partnership trade pact could limit the availability of affordable medicines, according to World Health Organization chief Margaret Chan; A federal appeals court backed an earlier ruling invalidating four of five patents on the Cubicin antibiotic that Merck acquired with its $8.4 billion deal to buy Cubist Pharmaceuticals; Roche plans to close or sell four manufacturing sites and pare about 1,200 jobs in a restructuring program; and Mylan is poised to lose its hostile bid for Perrigo.
